Latest filing published 12 Mar 2026 for Integra Lifesciences Holdings CORP, €5,648. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Robert T. Davis Jr. is a declared insider of Integra Lifesciences Holdings Corp (chief executive), with filings sourced from SEC (Form 4). We count 12 filings; the first trade dates from 11 February 2022 and the latest from 10 March 2026.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 12 March 2026 came the latest disclosure, a share grant for €5,648 in Integra Lifesciences Holdings Corp. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations